Brief: Adaptive Biotechnologies announces plan to separate its MRD and Immune Medicine Businesses
15/06/2026 21:12
BRIEF-Adaptive Biotechnologies announces plan to separate its MRD and Immune Medicine Businesses June 15 (Reuters) - Adaptive Biotechnologies Corp ADPT.O:
ADAPTIVE BIOTECHNOLOGIES ANNOUNCES PLAN TO SEPARATE ITS MRD AND IMMUNE MEDICINE BUSINESSES
ADAPTIVE BIOTECHNOLOGIES - EXPECTS TO IDENTIFY IMMUNE MEDICINE SEPARATION PATH BY YEAR-END 2026
Source text: ID:nGNX9vVtCN
Further company coverage: ADPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile